Ondine Biomedical partners with CAN Health Network

Published 12/05/2025, 07:18
Ondine Biomedical partners with CAN Health Network

VANCOUVER - Ondine Biomedical Inc. (LON:OBI), a Canadian medical technology company, has become a member of the CAN Health Network, a national initiative designed to foster the adoption of Canadian healthcare innovations. This partnership aims to facilitate the expansion and impact of Ondine’s Steriwave® technology, which is focused on infection prevention.

The CAN Health Network, supported by federal funding, works to connect Canadian healthcare innovators with operators across the nation to promote the commercialization of homegrown solutions. Ondine’s integration into this network is expected to offer strategic support and market insights, aiding the company in scaling its technology within Canada and potentially on a global scale.

Ondine’s Steriwave is a nasal photodisinfection system that utilizes light-activated antimicrobials to eradicate pathogens, including those resistant to multiple drugs, without contributing to the issue of drug resistance. The technology has shown promising results in reducing post-surgical infections and delivering cost savings in healthcare settings.

A 14-year study led by Professor John Street at Vancouver General Hospital reported a 66.5% decrease in infections following spine surgeries, leading to recommendations for Steriwave’s adoption as a standard of care. Similarly, the Mid Yorkshire NHS Teaching Trust in the UK observed a 70% reduction in knee and hip infection rates with Steriwave compared to traditional care protocols. Estimates from the York Health Economics Consortium suggest that if Steriwave were widely adopted, UK hospitals could save up to £200 million annually by lowering surgical-site infections.

Carolyn Cross, CEO of Ondine Biomedical, expressed pride in joining the CAN Health Network and highlighted the opportunity to work alongside Canada’s leading healthcare innovators. The company’s goal is to broaden access to Steriwave and improve patient outcomes across Canada.

This move by Ondine Biomedical aligns with its commitment to enhancing health outcomes and contributing to a robust Canadian healthcare system. The information in this article is based on a press release statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.